Literature DB >> 19383051

Stem cells for enhancing recovery after stroke: a review.

Tim England1, Paul Martin, Philip M W Bath.   

Abstract

The potential application for stem cell therapy is vast, and development for use in ischaemic stroke is still in its infancy. Access to stem cells for research is contentious; however, stem cells are obtainable from both animal and human. Despite a limited understanding of their mechanisms of action, clinical trials assessing stem cells in human stroke have been performed. Trials are also underway evaluating haematopoietic precursors mobilised with granulocyte-colony stimulating factor, an approach offering an autologous means of administrating stem cells for therapeutic purposes. This review summarises current knowledge in regard to stem cells and their potential for helping improve recovery after stroke.

Entities:  

Mesh:

Year:  2009        PMID: 19383051     DOI: 10.1111/j.1747-4949.2009.00253.x

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  9 in total

1.  MRI stem cell tracking for therapy in experimental cerebral ischemia.

Authors:  Pedro Ramos-Cabrer; Mathias Hoehn
Journal:  Transl Stroke Res       Date:  2011-10-27       Impact factor: 6.829

Review 2.  Experimental approaches to study functional recovery following cerebral ischemia.

Authors:  Anu Lipsanen; Jukka Jolkkonen
Journal:  Cell Mol Life Sci       Date:  2011-05-29       Impact factor: 9.261

3.  Long-term evaluation of granulocyte-colony stimulating factor on hypoxic-ischemic brain damage in infant rats.

Authors:  Nancy Fathali; Tim Lekic; John H Zhang; Jiping Tang
Journal:  Intensive Care Med       Date:  2010-05-12       Impact factor: 17.440

4.  Indian Academy of Neurology: The Dasgupta Oration 2009, Neural regeneration with stem cells: Rebooting the brain.

Authors:  Alok Srivastava
Journal:  Ann Indian Acad Neurol       Date:  2009-07       Impact factor: 1.383

5.  Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression.

Authors:  Thorsten R Doeppner; Josephine Herz; André Görgens; Jana Schlechter; Anna-Kristin Ludwig; Stefan Radtke; Kyra de Miroschedji; Peter A Horn; Bernd Giebel; Dirk M Hermann
Journal:  Stem Cells Transl Med       Date:  2015-09-03       Impact factor: 6.940

6.  Mobilization of Stem Cells Using G-CSF for Acute Ischemic Stroke: A Randomized Controlled, Pilot Study.

Authors:  Kameshwar Prasad; Amit Kumar; Jitendra Kumar Sahu; M V P Srivastava; Sujata Mohanty; Rohit Bhatia; Shailesh B Gaikwad; Achal Srivastava; Vinay Goyal; Manjari Tripathi; Chandrashekar Bal; Nalini Kant Mishra
Journal:  Stroke Res Treat       Date:  2011-10-11

Review 7.  New perspectives in human stem cell therapeutic research.

Authors:  Alan Trounson
Journal:  BMC Med       Date:  2009-06-11       Impact factor: 8.775

8.  Imaging of VSOP labeled stem cells in agarose phantoms with susceptibility weighted and T2* weighted MR Imaging at 3T: determination of the detection limit.

Authors:  Donald Lobsien; Antje Y Dreyer; Albrecht Stroh; Johannes Boltze; Karl-Titus Hoffmann
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240

Review 9.  Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities.

Authors:  Thorsten R Doeppner; Dirk M Hermann
Journal:  Stem Cells Cloning       Date:  2010-11-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.